nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Between persuasion and compulsion: The case of COVID-19 vaccination in Canada
|
Dubé, Eve |
|
|
40 |
29 |
p. 3923-3926 |
artikel |
2 |
Comparison of performance of varicella vaccines via infectious disease modeling
|
Pillsbury, Matthew |
|
|
40 |
29 |
p. 3954-3962 |
artikel |
3 |
Corrigendum to “Considering human challenge trials for tuberculosis vaccine development” [Vaccine 40(2) (2022) 173–174]
|
Kleinwaks, Gavriel |
|
|
40 |
29 |
p. 3984 |
artikel |
4 |
Editorial Board/Aims and Scope
|
|
|
|
40 |
29 |
p. IFC |
artikel |
5 |
Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study
|
Savulescu, Camelia |
|
|
40 |
29 |
p. 3963-3974 |
artikel |
6 |
Factors associated with caregivers’ hesitancy to vaccinate children against influenza: A cross-sectional survey in China
|
Lai, Xiaozhen |
|
|
40 |
29 |
p. 3975-3983 |
artikel |
7 |
Have vaccine hesitancy models oversimplified a complex problem to our detriment? The Adapted Royal Society of Canada vaccine uptake framework
|
MacDonald, N.E. |
|
|
40 |
29 |
p. 3927-3930 |
artikel |
8 |
High seroprotection rates and geometric mean titre increases after repeated annual influenza vaccinations in a cohort of HIV-infected adults in Austria
|
Kitchen, Maria |
|
|
40 |
29 |
p. 3948-3953 |
artikel |
9 |
Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008–2018)
|
Hemming-Harlo, Maria |
|
|
40 |
29 |
p. 3942-3947 |
artikel |
10 |
Nanomedicine to deliver biological macromolecules for treating COVID-19
|
Wilson, Barnabas |
|
|
40 |
29 |
p. 3931-3941 |
artikel |
11 |
Working towards a sustainable, healthy market for vaccines: A framework to support evidence-based policymaking
|
Rodes-Sanchez, Marina |
|
|
40 |
29 |
p. 3919-3922 |
artikel |